Conclusion from report in Journal of Infection (link below)…
“The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population.”
31 May 2021.
Remember, this is the same test that was used by the pharma companies to validate the effect (efficacy) of the vaccines in clinical trials, and also the same test that is the “gold standard” to determine “cases” in the population and ultimately deaths attributed to SARS CoV-2.
Bud is a retired life sciences executive. Bud's entrepreneurial leadership exceeded three decades. He was the senior business development, marketing and sales executive at four public corporations, each company a supplier of analytical and life sciences instrumentation, software, consumables and service. Prior to those positions, his 19 year career in Hewlett-Packard Company's Analytical Products Group included worldwide sales and marketing responsibility for Bioscience Products, Global Accounts and the International Olympic Committee, as well as international management assignments based in Japan and Latin America. Bud has visited and worked in more than 65 countries and lived and worked in 3 countries.
budbromley 
And the same tool used to generate the digital vaccine sequences, Crazy stuff.
LikeLike